Anatomic Stage III Breast Cancer AJCC v8 trials recruiting in California
All Anatomic Stage III Breast Cancer AJCC v8 trials nationally
11
Recruiting in California
52
Cities with sites
Cities in California
Los Angeles 7Duarte 6Beverly Hills 3Irvine 3Lancaster 3Pasadena 3South Pasadena 3Upland 3Alhambra 2Arcadia 2Burbank 2La Jolla 2
Recruiting trials in California
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Breast Cancer Survivorship Biorepository
- Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
- Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
- Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
- Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
- Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer